These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22235834)

  • 21. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis.
    Iorga A; Dara L; Kaplowitz N
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice.
    Marques PE; Oliveira AG; Pereira RV; David BA; Gomides LF; Saraiva AM; Pires DA; Novaes JT; Patricio DO; Cisalpino D; Menezes-Garcia Z; Leevy WM; Chapman SE; Mahecha G; Marques RE; Guabiraba R; Martins VP; Souza DG; Mansur DS; Teixeira MM; Leite MF; Menezes GB
    Hepatology; 2015 Jan; 61(1):348-60. PubMed ID: 24824608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of animal models of drug-induced liver injury and analysis of possible mechanisms].
    Oda S; Yokoi T
    Yakugaku Zasshi; 2015; 135(4):579-88. PubMed ID: 25832838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of exacerbative effect of progesterone on drug-induced liver injury.
    Toyoda Y; Endo S; Tsuneyama K; Miyashita T; Yano A; Fukami T; Nakajima M; Yokoi T
    Toxicol Sci; 2012 Mar; 126(1):16-27. PubMed ID: 22157104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
    Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
    Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
    Mosedale M; Watkins PB
    Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-helper cell-mediated factors in drug-induced liver injury.
    Wang X; Zhang L; Jiang Z
    J Appl Toxicol; 2015 Jul; 35(7):695-700. PubMed ID: 25752261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
    Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
    Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
    Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
    Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice.
    Giustarini G; Kruijssen L; van Roest M; Bleumink R; Weaver RJ; Bol-Schoenmakers M; Smit J; Pieters R
    J Appl Toxicol; 2018 May; 38(5):753-765. PubMed ID: 29377180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell based approaches for evaluation of drug-induced liver injury.
    Greer ML; Barber J; Eakins J; Kenna JG
    Toxicology; 2010 Feb; 268(3):125-31. PubMed ID: 19683031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing.
    Lu J; Einhorn S; Venkatarangan L; Miller M; Mann DA; Watkins PB; LeCluyse E
    Toxicol Sci; 2015 Sep; 147(1):39-54. PubMed ID: 26092927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac.
    Selvaraj S; Oh JH; Borlak J
    Arch Toxicol; 2020 Aug; 94(8):2733-2748. PubMed ID: 32372211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injury.
    Wuillemin N; Terracciano L; Beltraminelli H; Schlapbach C; Fontana S; Krähenbühl S; Pichler WJ; Yerly D
    Am J Pathol; 2014 Jun; 184(6):1677-82. PubMed ID: 24731753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling.
    Kuijper IA; Yang H; Van De Water B; Beltman JB
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):5-17. PubMed ID: 27609146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
    Whritenour J; Ko M; Zong Q; Wang J; Tartaro K; Schneider P; Olson E; Van Volkenburg M; Serrano J; Hayashi P; Fontana R; Chalasani N; Bonkovsky HL
    J Immunotoxicol; 2017 Dec; 14(1):31-38. PubMed ID: 28121193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.